Multidisciplinary Approach to Treating Advanced Endometrial Cancer

Description

New drug combinations have emerged for the treatment management of advanced endometrial cancer. Learn the benefits of having your multidisciplinary team involved in the management of toxicities in these patients.

Recorded live on Tuesday, February 14, 2023

Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.

Faculty Information

	Ambar Khan, PharmD, BCOP Speciality Pratice Pharmacy - Gynecology/Oncology The James as The Ohio State University Wexner Medical Center Department of Pharmacy USA
	Domenica "Ketta" Lorusso, MD, PhD Associate Professor of Obstetrics and Gynecology Fondazione Policlinico Universitario A Gemelli Italy
	Marta Moscatelli Research Nurse Fondazione Policlinico Universitario A Gemelli Italy
	Floor Backes, MD Director of Clincial Research and Fellowship Director for the Division of Gynecologic Oncology The Ohio State University Wexner Medical Center James Comprehensive Cancer Center USA

Supported in part by

Summary

Availability:

On-Demand

Cost:

FREE

Create Account

Recommended

An Evolving Frontier: Endometrial Cancer Treatment

FREE

Master Class: Managing Toxicities with TKIs in combination with Checkpoint Inhibitors in Endometrial Cancer

FREE

Endometrial Cancer Tumor Board: Matching the right therapy to the right patient

FREE

Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer

FREE

Mismatch repair endometrial cancer, what to do at first recurrence and beyond?

FREE

Immunotherapy and its impact on overall survival in patients with recurrent endometrial cancer

FREE

Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications

FREE

Moving Towards Personalized Therapy in Endometrial Cancer

FREE

IGCS 2024 Cervical Master Sessions: Moving Forwards

FREE

Phase II PICCOLO Trial Results

Results of Phase II PICCOLO Trial are available. Dr. Angeles Alvarez Secord, PI of PICCOLO Trial, and Dr. Wendel Naumann discuss results of MIRV in Recurrent Platinum-Sensitive Ovarian Cancer with High Folate Receptor-Alpha Expression.

FREE